Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 2/20 | 0.61 |
| ▸ | MAOB | P27338 | 1/20 | 0.61 |
| ▸ | KDM5A | P29375 | 1/20 | 0.61 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.61 |
| ▸ | NPY2R | P49146 | 7/20 | 0.61 |
| ▸ | NPY4R | P50391 | 7/20 | 0.61 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.61 |
| ▸ | NPY1R | P25929 | 6/20 | 0.61 |
| ▸ | NTSR1 | P30989 | 4/20 | 0.60 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.60 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.58 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.58 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.57 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.57 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17525278 | 0.95 | NTSR1 (0.58) | KDM1AMAOBKDM5AKDM1BNPY2R | |
| SCHEMBL31738531 | 0.91 | NTSR1 (0.66) | KDM1AMAOBKDM5AKDM1BNPY2R | |
| SCHEMBL31548697 | 0.91 | NTSR1 (0.66) | KDM1AMAOBKDM5AKDM1BNPY2R | |
| SCHEMBL17527539 | 0.89 | NTSR1 (0.60) | KDM1AMAOBKDM5AKDM1BNPY1R | |
| SCHEMBL29368585 | 0.89 | NTSR1 (0.63) | KDM1ANPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30957024 | 0.88 | KDM1A (0.61) | KDM1ANPY2RNPY4RNPY5RNPY1R | |
| Neurotensin SCHEMBL30483709 | 0.88 | KDM1A (0.61) | KDM1ANPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30176453 | 0.86 | NPY2R (0.64) | KDM1AMAOBKDM5AKDM1BNPY2R | |
| SCHEMBL30429908 | 0.86 | KDM1A (0.65) | KDM1AMAOBKDM5AKDM1BNPY2R | |
| SCHEMBL30495647 | 0.85 | NPY2R (0.77) | NPY2RNPY4RNPY5RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190076546-A1 | ENHANCED ACTIVE AGENTS | MAHA THERAPEUTICS, INC. | 2019-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190076546-A1 | ENHANCED ACTIVE AGENTS | SERPINA6, SERPINB1, SERPINA3 | KDM1A 4108/4885MAOB 2850/4885KDM5A 3786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.